Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: E9B0X7
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0016491 | oxidoreductase activity | 2 | 10 |
GO:0140575 | transmembrane monodehydroascorbate reductase activity | 3 | 10 |
GO:0005488 | binding | 1 | 1 |
GO:0020037 | heme binding | 4 | 1 |
GO:0046906 | tetrapyrrole binding | 3 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.261 |
CLV_NRD_NRD_1 | 44 | 46 | PF00675 | 0.405 |
CLV_NRD_NRD_1 | 84 | 86 | PF00675 | 0.312 |
CLV_PCSK_KEX2_1 | 166 | 168 | PF00082 | 0.342 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.260 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.334 |
CLV_PCSK_PC1ET2_1 | 166 | 168 | PF00082 | 0.342 |
CLV_PCSK_PC7_1 | 80 | 86 | PF00082 | 0.257 |
CLV_PCSK_SKI1_1 | 157 | 161 | PF00082 | 0.383 |
CLV_PCSK_SKI1_1 | 74 | 78 | PF00082 | 0.257 |
DEG_APCC_DBOX_1 | 19 | 27 | PF00400 | 0.458 |
DOC_ANK_TNKS_1 | 28 | 35 | PF00023 | 0.438 |
DOC_MAPK_gen_1 | 28 | 35 | PF00069 | 0.482 |
DOC_MAPK_MEF2A_6 | 175 | 183 | PF00069 | 0.281 |
DOC_MAPK_MEF2A_6 | 28 | 37 | PF00069 | 0.448 |
DOC_PP1_SILK_1 | 153 | 158 | PF00149 | 0.298 |
DOC_PP4_MxPP_1 | 202 | 205 | PF00568 | 0.255 |
LIG_Actin_WH2_2 | 112 | 127 | PF00022 | 0.181 |
LIG_Actin_WH2_2 | 143 | 159 | PF00022 | 0.298 |
LIG_Actin_WH2_2 | 66 | 82 | PF00022 | 0.349 |
LIG_EH1_1 | 56 | 64 | PF00400 | 0.285 |
LIG_FHA_1 | 178 | 184 | PF00498 | 0.361 |
LIG_FHA_1 | 208 | 214 | PF00498 | 0.447 |
LIG_FHA_2 | 47 | 53 | PF00498 | 0.279 |
LIG_LIR_Gen_1 | 120 | 129 | PF02991 | 0.315 |
LIG_LIR_Nem_3 | 120 | 124 | PF02991 | 0.262 |
LIG_LYPXL_yS_3 | 128 | 131 | PF13949 | 0.257 |
LIG_MYND_2 | 204 | 208 | PF01753 | 0.211 |
LIG_PCNA_PIPBox_1 | 187 | 196 | PF02747 | 0.181 |
LIG_SH2_CRK | 121 | 125 | PF00017 | 0.257 |
LIG_SH2_CRK | 56 | 60 | PF00017 | 0.247 |
LIG_SH2_STAP1 | 198 | 202 | PF00017 | 0.372 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.294 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.542 |
LIG_SH3_2 | 162 | 167 | PF14604 | 0.494 |
LIG_SH3_3 | 156 | 162 | PF00018 | 0.488 |
LIG_SUMO_SIM_par_1 | 178 | 184 | PF11976 | 0.315 |
LIG_TRFH_1 | 158 | 162 | PF08558 | 0.527 |
LIG_TYR_ITIM | 119 | 124 | PF00017 | 0.294 |
LIG_WRC_WIRS_1 | 103 | 108 | PF05994 | 0.349 |
MOD_CK1_1 | 216 | 222 | PF00069 | 0.298 |
MOD_CK2_1 | 114 | 120 | PF00069 | 0.181 |
MOD_CK2_1 | 90 | 96 | PF00069 | 0.593 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.254 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.546 |
MOD_GSK3_1 | 177 | 184 | PF00069 | 0.331 |
MOD_GSK3_1 | 203 | 210 | PF00069 | 0.294 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.252 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.480 |
MOD_NEK2_1 | 207 | 212 | PF00069 | 0.358 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.432 |
MOD_PK_1 | 175 | 181 | PF00069 | 0.246 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.442 |
MOD_PKA_2 | 90 | 96 | PF00069 | 0.388 |
MOD_Plk_1 | 6 | 12 | PF00069 | 0.592 |
MOD_Plk_4 | 102 | 108 | PF00069 | 0.522 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.339 |
MOD_Plk_4 | 151 | 157 | PF00069 | 0.268 |
MOD_Plk_4 | 203 | 209 | PF00069 | 0.288 |
MOD_SUMO_for_1 | 4 | 7 | PF00179 | 0.547 |
MOD_SUMO_rev_2 | 71 | 79 | PF00179 | 0.298 |
TRG_ENDOCYTIC_2 | 121 | 124 | PF00928 | 0.294 |
TRG_ENDOCYTIC_2 | 128 | 131 | PF00928 | 0.245 |
TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.249 |
TRG_ER_diArg_1 | 28 | 30 | PF00400 | 0.461 |
TRG_ER_diArg_1 | 84 | 86 | PF00400 | 0.460 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JNM4 | Bodo saltans | 26% | 95% |
A0A1X0P2F3 | Trypanosomatidae | 26% | 91% |
A0A3Q8IC17 | Leishmania donovani | 87% | 100% |
A4HID6 | Leishmania braziliensis | 67% | 100% |
A4I5N2 | Leishmania infantum | 83% | 100% |
C9ZR03 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 24% | 95% |
Q4Q789 | Leishmania major | 89% | 100% |
V5BPF8 | Trypanosoma cruzi | 24% | 94% |